The 2011 marriage between Kinetic Concepts Inc., Apax Partners and a pair of Canadian pension funds wasn’t your typical merger.
MassDevice Q&A
MassDevice.com Q&A: Monarch Medical CEO Dr. Wilson Constantine
Monarch Medical’s mission is to transform how hospitals and caregivers handle "drugs of concern," or compounds that, when mismanaged, can lead to injuries or even death – the aptly named "never events" that ought to be anathema to healthcare.
Sunshine Act: Compliance lawyer Jennifer Geetter looks beyond the countdown
With 7 days until the federal Sunshine rules kick in, companies are hammering out the final details of their physician payment reporting strategies, but they’d do well to look beyond the August 1 deadline.
Investment, reimbursement and the FDA | 5 Questions with Amar Sawhney
Medtech super-entrepreneur Amar Sawhney has not been shy about sharing his success story.
MassDevice.com Q&A: K2M co-founder & CEO Eric Major
Revenues in the spine industry have been flat for several years now, with the largest players in the space reporting declines or low-single-digit growth.
T2 Biosystems aims to revolutionize diagnostics
When MassDevice.com last spoke with T2 Biosystems CEO John McDonough, in August 2009, the 22-worker firm was still developing a novel use for MRI technology – diagnostics.
T2’s device uses magnetic resonance to identify pathogens in just about any kind of sample, eliminating the need for time-consuming blood culture work.
You can make a buck, but can you make a difference? | 5 questions for Dean Kamen
Dean Kamen is perhaps most commonly known for having invented the Segway, but he’s also invented a prosthetic robotic arm, a portable dialysis system and a robotic wheelchair that can climb stairs.
Diabetes in the iPhone age: Q&A with Glooko CEO Rick Altinger
Silicon Valley mHealth company Glooko is rocketing forward in the mobile diabetes management space since its inception less than 3 years ago, boasting multiple FDA clearances, wide-ranging industry partnerships and a growing base of patient users and healthcare provider subscribers.
Just last month, Glooko won FDA clearance for the 2nd generation of its iPhone diabetes management app and launched the 1st subscriber portal at San Diego’s Scripps Whittier Diabetes Institute.
Podcast: Medtronic CEO Omar Ishrak on emerging markets, economic value and the medtech tax
Medical device tax: Winners and losers
The 2.3% medical device tax has been in effect for about half a year now, meaning some of the myths about the levy are being slowly stripped away.
As it turns out, the retail exemption contained in the IRS codes, protecting over-the-counter medical devices from the tax, aren’t as cut-and-dried as they seem. Neither are the oft-mentioned price increases that medical device makers have posed as a way to deal with the excise tax.
Podcast: Allergan CEO David Pyott at the MassDevice Big 100 West
Allergan (NYSE:AGN) CEO David Pyott likes to describe himself as a "mountaineer," a "born marketer," and a bit of a masochist, but there’s 1 thing the man undoubtedly is: A great interview.